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ABSTRACT 
Background and objective: In sub-Saharan Africa, data on prevalence, risk factors and pathobiology of carotid atherosclerosis are scarce. We 
aimed to investigate the relationship between biomarkers of endothelial dysfunction and carotid atherosclerosis. 
Methods: Carotid ultrasound was performed in 66 patients. Plasma concentration of ICAM-1, PAI-1, VEGF, and soluble thrombomodulin were 
measured by ELISA. A univariable logistic regression analysis was performed to study the relationship between carotid atherosclerosis, 
biomarkers of endothelial dysfunction, and various demographic and clinical parameters of the participants.  
Results: The mean age of the participants was 58.7 years (95% CI: 54.4 – 63.1). Carotid atherosclerosis was diagnosed in 39.4% (95% CI: 27.6 
– 52.2). In the univariable logistic regression, the following factors were associated with carotid atherosclerosis: age > 45 years (OR = 12.0, 95% 
CI: 1.4 – 98.8, p = 0.02), hypertension (OR = 3.8, 95% CI: 1.2 – 12.1, p =0.02), and high-level of soluble thrombomodulin (OR = 3.4, 95% CI: 
1.2 – 10.0, p = 0.02). 
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Conclusions: There is an association between high levels of soluble thrombomodulin and carotid atherosclerosis in Malawian adults. Further 
studies with a larger sample size are needed to confirm our findings in other African populations. 
 
Keywords: Endothelial dysfunction, HIV infection, Africa, stroke, atherosclerosis, carotid intima-media thickness. 
1. INTRODUCTION 
Several studies carried out in Western countries have established that endothelial dysfunction triggered by various cardiovascular risk factors is 
the primum movens of the arterial remodelling process leading to atherosclerosis and then atherothrombotic events [1, 2]. In sub-Saharan Africa, 
data on prevalence, risk factors and pathobiology of carotid atherosclerosis are scarce. To address this knowledge gap, we have conducted 
several prospective studies in Malawi, a country with > 10% prevalence of HIV [3-6]. In one study, we showed that endothelial dysfunction 
persists despite antiretroviral therapy and could, therefore, contribute to the development of atherosclerosis [5]. In a subsequent study, we 
reported a 39.4% prevalence of carotid atherosclerosis in a sample of 66 patients presenting with an acute stroke-like syndrome [7]. Plasma 
samples were also collected from the patients to investigate the relationship between biomarkers of endothelial dysfunction and carotid 
atherosclerosis. Here, we present and discuss the findings of these complimentary analyses. 
2. METHODS 
2.1 Selection of patients and ultrasound assessment 
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Participants were recruited consecutively from April to August 2017 at the Queen Elizabeth Central Hospital which is the largest referral 
hospital in Malawi. The presence of any cardiovascular risk factor was recorded according to previously reported definitions [7].  
Carotid ultrasound examination was performed on the day of enrolment (JKT) using the CX50 portable ultrasound device (Philips, Amsterdam, 
NL). Details of the examination protocol and criteria for the interpretation of findings were reported previously [7]. Briefly, the examination 
comprised a semi-automated assessment of the carotid intima-media thickness (cIMT) and a grading of any existing stenosis. Carotid 
atherosclerosis was defined as abnormal intima-media thickness or presence of carotid plaque with or without stenosis.  
In order to define abnormal cIMT, the following age-specific cut-offs were applied: 0.60 mm (30-39 years old), 0.65 mm (40-49 years old), 0.70 
mm (50-59 years old), 0.75 mm (60-69 years old), and 0.80 mm (≥70 years old). In the absence of reference values specific to African 
populations, the reference cut-off in each age category was chosen close to the upper limit of the 95% confidence interval of the mean cIMT for 
participants without cardiovascular risk factors enrolled in the PARC study (Paroi Artérielle et Risque Cardiovasculaire) [8]. Results of the 
PARC study suggest that the normal aging of the arterial vessel wall is associated with intima-media thickening by approximately 0.5 mm per 
decade. In patients with cardiovascular risk factors, the cIMT is typically higher that the indicated cut-off in each age category and is dependent 
on the number of cardiovascular risk factors as illustrated in the Mannheim consensus guidelines [9].  
2.2 Measurement of biomarkers of endothelial dysfunction 
We used ELISA kits from Abcam ® (Abcam plc, Cambridge, United Kingdom) to measure the plasma concentrations of biomarkers of 
endothelial activation (intercellular adhesion molecule -ICAM-1), endothelial damage (plasminogen activator inhibitor 1 - PAI-1), angiogenesis 
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(VEGF), and coagulopathy (soluble thrombomodulin – sTM). SimpleStep® ELISA kits were used for ICAM-1, PAI-1, and sTM while the 
standard kit was used for VEGF. All samples were run in duplicates and samples with an individual coefficient of variability (CV) greater than 
25% were retested in duplicates.  
All the ELISA tests were performed according to the manufacturer’ instructions with exception of the washing steps that were performed with an 
automated washer (ASYS Atlantis®, Biochrom Ltd, Cambridge, UK) using a mixture of phosphate buffer saline and Tween 20 (0.05% v/v). The 
plates were read at 450 nm using an automated microplate reader (EZ Read®, Biochrom Ltd, Cambridge, UK). The standard curves were built 
using 4-parameter logistic regression. The mean intra-assay CV for ICAM-1, PAI-1, VEGF, and sTM was 3.3%, 3.2%, 8.0%, and 3.1% 
respectively (accepted value < 10%). The mean inter-assay CV for ICAM-1, PAI-1, VEGF, and sTM was 4.1%, 4.1%, 9.0%, and 2.8% 
respectively (accepted value < 15%). 
2.3 Statistical analysis 
Participants’ demographic and clinical parameters were summarized as proportions and means with 95% confidence interval for categorical and 
numerical variables, respectively. The relationship between plasma levels of biomarkers of endothelial dysfunction and cIMT was explored 
using the Spearman rank correlation test.  
A univariable logistic regression analysis was performed to study the relationship between carotid atherosclerosis (dependent variable) and 
various demographic and clinical parameters of the participants. Following the approach in our previous publications [5, 6], age was 
dichotomized at 45 years while biomarkers were dichotomized at the third tertile of the distribution of plasma concentration values (low versus 
Jou
nal
 Pr
e-p
roo
f
Journal Pr -proof
Endothelial dysfunction and carotid atherosclerosis in Malawian adults Page 6 of 13 
 
Kamtchum-Tatuene et al. 
high level). A multivariable analysis was not performed due to the small sample size. All statistical tests were two-tailed and statistical 
significance was defined as p ≤ 0.05. Analyses were performed using the software STATA (version 13, StataCorp, College Station, TX, USA). 
3. RESULTS 
The mean age of the participants was 58.7 years (95% CI: 54.4 – 63.1). There were 22 HIV-positive patients and 77.3% were on antiretroviral 
therapy. HIV+ cases were younger (mean age 43.6 versus 66.3, p<0.001) and their mean CD4+ T cell count was 223/mm3. There was no 
difference in the levels of biomarkers between HIV-positive and HIV-negative patients. The baseline characteristics of the participants are 
summarized in Table 1.  
There was no correlation between the plasma concentration of the biomarkers of endothelial dysfunction and the value of cIMT (Spearman rank 
correlation coefficient of -0.24, -0.03, 0.11, 0.11 for ICAM-1, PAI-1, sTM, and VEGF, respectively). 
In the univariable logistic regression (Table 2), the following factors were associated with carotid atherosclerosis: age > 45 years (OR = 12.0, 
95% CI: 1.4 – 98.8, p = 0.02), hypertension (OR = 3.8, 95% CI: 1.2 – 12.1, p =0.02), and high-level of soluble thrombomodulin (OR = 3.4, 95% 
CI: 1.2 – 10.0, p = 0.02). 
 
4. DISCUSSION 
This study is the first to investigate the relationship between biomarkers of endothelial dysfunction and carotid atherosclerosis in sub-Saharan 
Africa. The association between high levels of soluble thrombomodulin and carotid atherosclerosis is in line with findings in Western 
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populations [10, 11]. Soluble thrombomodulin is an endothelial membrane glycoprotein also known as CD141. It is a marker of endothelial 
injury and higher plasma levels have been associated with other risk factors of atherosclerosis, notably age and hypertension [12]. In this study, 
patients with carotid atherosclerosis had a higher mean age and a higher prevalence of hypertension, which could contribute to the association 
between high levels of soluble thrombomodulin and carotid atherosclerosis. Due to the small sample size of this exploratory study, we could not 
reliably explore the independence of the association in a multivariable analysis. Further studies with a larger sample size are, therefore, needed to 
confirm our findings in African populations and investigate the performance of biomarkers of endothelial dysfunction as predictors of 
cardiovascular events. The small sample size likely also explains why our analysis did not show an association between carotid atherosclerosis 
and other established drivers of endothelial dysfunction and atherosclerosis, notably smoking, diabetes mellitus, adiposity, and HIV infection 
[13-16]. Specifically, for HIV-positive patients who are younger, longitudinal studies are needed to investigate if the persistence of HIV-induced 
endothelial dysfunction has a significant and independent impact on the incidence of carotid atherosclerosis and whether antiretroviral or anti-
inflammatory drugs are useful to prevent its progression and cerebrovascular consequences. Such studies should ideally be performed on large 
sample size populations and follow international consensus recommendations for the assessment of subclinical and clinical atherosclerosis in 
order to avoid generating more heterogeneous or contradictory results [17]. 
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Table 1: Participants’ baseline characteristics 
Characteristics 
Carotid atherosclerosis 
Yes (n = 26) No (n = 40) 
Age (years) 63.0 (57.7 – 68.2) 56.1 (49.7 – 62.4) 
Age > 45 years 25 (96.2) 27 (67.5) 
Men 13 (50.0) 15 (37.5) 
HIV positive 7 (27.0) 15 (37.5) 
On ART 7 (26.9) 10 (25.0) 
Smoking 3 (11.5) 5 (12.5) 
Alcohol consumption 4 (15.4) 9 (22.5) 
Hypercholesterolemia 3 (11.5) 0 (0.0) 
Hypertension 21 (80.8) 21 (52.5) 
Diabetes mellitus 5 (19.2) 6 (15.0) 
Waist-hip ratio 0.9 (0.9 – 1.0) 0.9 (0.8 – 0.9) 
CD4+ count 472.3 (377.7 – 566.9) 421.2 (320.2 – 522.2) 
ICAM-1 (ng/mL) 377.4 (244.2 – 510.6) 404.7 (268.4 – 540.9) 
PAI-1 (ng/mL) 43.0 (26.8 – 59.2) 49.3 (31.0 – 67.5) 
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sTM (ng/mL) 8.1 (5.6 – 10.6) 6.2 (5.1 – 7.4) 
VEGF (pg/mL) 12.8 (0.0 – 26.7) 4.4 (0.9 – 8.0) 
* Data are presented as N (%) or mean (95%CI) 
 
Table 2: Univariable analysis of factors associated with carotid atherosclerosis 
Characteristic 
Univariable analysis 
OR 95% CI p 
HIV infection 0.6 0.2 – 1.8 0.38 
Age > 45 12.0 1.4 – 98.8 0.02 
Male 1.6 0.6 – 4.5 0.32 
Hypertension 3.8 1.2 – 12.1 0.02 
Diabetes mellitus 1.3 0.4 – 5.0 0.65 
Smoking 0.9 0.2 – 4.2 0.91 
Waist-hip ratio (3rd 
tertile) 
1.9 0.7 – 5.5 0.22 
ART started 1.1 0.4 – 3.4 0.86 
High level of ICAM-1 0.8 0.3 – 2.4 0.72 
High level of PAI-1 1.1 0.4 – 3.1 0.86 
High level of sTM 3.4 1.2 – 10.0 0.02 
High level of VEGF 1.8 0.6 – 5.5 0.32 
* There were 3 patients with hypercholesterolemia and they all had carotid atherosclerosis 
 
HIGHLIGHTS 
High levels of soluble thrombomodulin are associated with carotid atherosclerosis. 
Age > 45 years and hypertension are also associated with carotid atherosclerosis. 
Mannheim consensus criteria for assessing carotid intima-media thickness and plaque. 
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